Stage 1 - 2015 (months 1-3)

1.1. Project web page

1.2. Delivery of stable plasmonic nanoparticles (PNPs) with well defined properties

1.3. Financial and scientific intermediary reports

Stage 2 - 2016 (months 4-15)

2.1. Delivery of stable, biocompatible and sensitive SERS tagged-nanoparticles

2.2. Delivery of multifunctional nanocarriers based on SERS-encoded and drug-loaded plasmonic nanoparticles for image-guided treatment of ovarian cancer cells

2.3. Collection of optical and morphological properties of the fabricated multifunctional nanocarriers

2.4. Updated list of scientific publications and communications at conferences

2.5. Financial and scientific intermediary reports

Stage 3 - 2017 (months 16-24)

3.1. Delivery of multifunctional nanocarriers with targeted chemotherapeutic properties against ovarian cancer cells

3.2. Delivery of optimal theranostic agents specifically addressed on ovarian cancer

3.3. Report on the combined functionalities (diagnostic imaging & therapy) of the fabricated theranostic agents on ovarian cancer cells

3.4. Updated list of scientific publications and communications at conferences

3.5. Financial and scientific final reports